The latest data shows that British American Tobacco’s Vuse e-cigarette brand continues to gradually expand its lead over Juul in the US market.

Vuse’s market share rose to 35.5% from 35.1, while Juul’s fell to 32.9% from 33.1%, according to Nielsen’s latest analysis of convenience store data for the four weeks ended June 18. In the latest report, NJoy fell from 3% to 2.9%, and Fontem Ventures’ blu eCigs fell from 1.9% to 1.7%.

This is the first report from Nielsen since the U.S. Food and Drug Administration (FDA) announced last Thursday that Juul Labs Inc. was required to remove all vaping products from U.S. shelves.

The FDA rejected Juul’s premarket tobacco product application, saying they “lacked sufficient evidence of the product’s toxicological characterization to demonstrate that the product was marketed to protect public health.” As a result, Juul “must stop selling and distributing these products. In addition, these products currently on the U.S. market must be removed or face enforcement action.”

Joe Murillo, chief regulatory officer of Juul Labs, said on Tuesday: “Following receiving an emergency temporary injunction, we are now seeking the ability to continue to provide our products to adult smokers while the court appeals, and conduct scientific and Evidence-based access.” “We remain confident in the science and evidence that we can demonstrate that our products actually meet statutory standards ‘fit for the protection of public health’.”

Cynthia Chen
Email: Cynthia@intl4.aierbaita.com
Mobile/whatsapp/wechat: +8615751339879
Nannning Aierbaita company/ Shenzhen Aierbaita company